| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |